SC-51322

• Description :

  SC-51322 is a potent and selective antagonist of prostaglandin E2 (PGE2) receptor (EP 1), with a pA2 of 8.1. SC-51322 has the pain-relieving effect[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H301

• Target :

  Prostaglandin Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/sc-51322.html

• Purity :

  98.93

• Solubility :

  DMSO : 20 mg/mL (ultrasonic)

• Smiles :

  O=C(N1C2=CC(Cl)=CC=C2OC3=CC=CC=C3C1)NNC(CCSCC4=CC=CO4)=O

• Molecular Formula :

  C22H20ClN3O4S

• Molecular Weight :

  457.93

• Precautions :

  H301

• References & Citations :

  [1]Hallinan EA, et, al. 8-chlorodibenz[b, f][1,4]oxazepine-10 (11H) -carboxylic acid,2-[3-[2- (furanylmethyl) thio]-1-oxopropyl]hydrazide (SC-51322) : A potent PGE2 antagonist and analgesic. Bioorganic & Medicinal Chemistry Letters. Feb 1994. 4 (3) : 509-514.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  EP

• CAS Number :

  [146032-79-3]